Loading...
Keywords
Last Name
Institution
 Back to Details

Connection

Mark Clements to Sweden

This is a "connection" page, showing publications Mark Clements has written about Sweden.

 
Connection Strength
  
 
 
1.198
  
  1. Rai B, Nordstr?m T, Lantz A, Lund RL, Kuja-Halkola R, Rado M, ?berg S, Hao S, Du X, Clements M. Spatio-temporal variation in prostate cancer testing in Stockholm: A population-based study. PLoS One. 2024; 19(8):e0308254.
    View in: PubMed
    Score: 0.242
  2. Hao S, Karlsson A, Heintz E, Elfstr?m KM, Nordstr?m T, Clements M. Cost-Effectiveness of Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study. Value Health. 2021 12; 24(12):1763-1772.
    View in: PubMed
    Score: 0.196
  3. Hao S, ?stensson E, Eklund M, Gr?nberg H, Nordstr?m T, Heintz E, Clements M. The economic burden of prostate cancer - a Swedish prevalence-based register study. BMC Health Serv Res. 2020 May 20; 20(1):448.
    View in: PubMed
    Score: 0.180
  4. Clements M, Matuleviciene V, Attvall S, Ekelund M, Pivodic A, Dahlqvist S, Fahl?n M, Haraldsson B, Lind M. Predicting the effectiveness of insulin pump therapy on glycemic control in clinical practice: a retrospective study of patients with type 1 diabetes from 10 outpatient diabetes clinics in Sweden over 5 years. Diabetes Technol Ther. 2015 Jan; 17(1):21-8.
    View in: PubMed
    Score: 0.124
  5. M?ller A, Schwamborn K, Spillmann A, Hoogstraate J, Szulkin R, Akre O, Egevad L, Clements M, Aly M. Travel vaccines are strongly associated to reduced mortality in prostate cancer patients - a real effect or residual confounding? Vaccine. 2022 06 15; 40(27):3797-3801.
    View in: PubMed
    Score: 0.052
  6. Forss A, Clements M, Bergman D, Roelstraete B, Kaplan GG, Myrelid P, Halfvarson J, Ol?n O, Ludvigsson JF. A nationwide cohort study of the incidence of inflammatory bowel disease in Sweden from 1990 to 2014. Aliment Pharmacol Ther. 2022 03; 55(6):691-699.
    View in: PubMed
    Score: 0.050
  7. Nordstr?m T, Discacciati A, Bergman M, Clements M, Aly M, Annerstedt M, Glaessgen A, Carlsson S, J?derling F, Eklund M, Gr?nberg H. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial. Lancet Oncol. 2021 09; 22(9):1240-1249.
    View in: PubMed
    Score: 0.049
  8. Dahl?n T, Clements M, Zhao J, Olsson ML, Edgren G. An agnostic study of associations between ABO and RhD blood group and phenome-wide disease risk. Elife. 2021 04 27; 10.
    View in: PubMed
    Score: 0.048
  9. Anderz?n J, Hermann JM, Samuelsson U, Charalampopoulos D, Svensson J, Skrivarhaug T, Fr?hlich-Reiterer E, Maahs DM, Akesson K, Kapellen T, Fritsch M, Birkebaek NH, Drivvoll AK, Miller K, Stephenson T, Hofer SE, Fredheim S, Kummernes SJ, Foster N, Amin R, Hilgard D, Rami-Merhar B, Dahl-J?rgensen K, Clements M, Hanas R, Holl RW, Warner JT. International benchmarking in type 1 diabetes: Large difference in childhood HbA1c between eight high-income countries but similar rise during adolescence-A quality registry study. Pediatr Diabetes. 2020 06; 21(4):621-627.
    View in: PubMed
    Score: 0.045
  10. Plym A, Clements M, Voss M, Holmberg L, Stattin P, Lambe M. Duration of sick leave after active surveillance, surgery or radiotherapy for localised prostate cancer: a nationwide cohort study. BMJ Open. 2020 03 09; 10(3):e032914.
    View in: PubMed
    Score: 0.045
  11. Charalampopoulos D, Hermann JM, Svensson J, Skrivarhaug T, Maahs DM, Akesson K, Warner JT, Holl RW, Birkeb?k NH, Drivvoll AK, Miller KM, Svensson AM, Stephenson T, Hofer SE, Fredheim S, Kummernes SJ, Foster N, Hanberger L, Amin R, Rami-Merhar B, Johansen A, Dahl-J?rgensen K, Clements M, Hanas R. Exploring Variation in Glycemic Control Across and Within Eight High-Income Countries: A Cross-sectional Analysis of 64,666 Children and Adolescents With Type 1 Diabetes. Diabetes Care. 2018 06; 41(6):1180-1187.
    View in: PubMed
    Score: 0.039
  12. Hed?n St?hl C, Lind M, Svensson AM, Kosiborod M, Gudbj?rnsdottir S, Pivodic A, Clements M, Rosengren A. Long-term excess risk of stroke in people with Type 2 diabetes in Sweden according to blood pressure level: a population-based case-control study. Diabet Med. 2017 04; 34(4):522-530.
    View in: PubMed
    Score: 0.036
  13. Tancredi M, Rosengren A, Svensson AM, Kosiborod M, Pivodic A, Gudbj?rnsdottir S, Wedel H, Clements M, Dahlqvist S, Lind M. Excess Mortality among Persons with Type 2 Diabetes. N Engl J Med. 2015 Oct 29; 373(18):1720-32.
    View in: PubMed
    Score: 0.033
  14. Lind M, Svensson AM, Kosiborod M, Gudbj?rnsdottir S, Pivodic A, Wedel H, Dahlqvist S, Clements M, Rosengren A. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med. 2014 Nov 20; 371(21):1972-82.
    View in: PubMed
    Score: 0.031
  15. Carlsson BM, Attvall S, Clements M, Gumpeny SR, Pivodic A, Sternemalm L, Lind M. Insulin pump-long-term effects on glycemic control: an observational study at 10 diabetes clinics in Sweden. Diabetes Technol Ther. 2013 Apr; 15(4):302-7.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.